[Psychopharmacologic profile of a potentially antidepressant compound of the 5-hydroxymethyl 2-oxazolidinone series].
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D004569:Electroencephalography; D051379:Mice; D008995:Monoamine Oxidase / Q000032:analysis; D010113:Oxyphenbutazone; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors*
D000928:Antidepressive Agents; D012110:Reserpine; D008995:Monoamine Oxidase; D010113:Oxyphenbutazone
Profil psychopharmacologique d'un antidépresseur potentiel appartenant à la série de l'hydroxyméthyl-5 oxazolidinone-2